Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs TORRENT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON TORRENT PHARMA BIOCON /
TORRENT PHARMA
 
P/E (TTM) x 36.9 68.8 53.6% View Chart
P/BV x 4.1 9.2 45.0% View Chart
Dividend Yield % 0.2 3.0 5.9%  

Financials

 BIOCON    TORRENT PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-22
TORRENT PHARMA
Mar-22
BIOCON /
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs4243,304 12.8%   
Low Rs3152,478 12.7%   
Sales per share (Unadj.) Rs68.2502.8 13.6%  
Earnings per share (Unadj.) Rs8.245.9 17.7%  
Cash flow per share (Unadj.) Rs14.985.1 17.6%  
Dividends per share (Unadj.) Rs0.5048.00 1.0%  
Avg Dividend yield %0.11.7 8.2%  
Book value per share (Unadj.) Rs68.5351.8 19.5%  
Shares outstanding (eoy) m1,200.60169.22 709.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.45.8 94.3%   
Avg P/E ratio x45.362.9 72.0%  
P/CF ratio (eoy) x24.734.0 72.8%  
Price / Book Value ratio x5.48.2 65.6%  
Dividend payout %6.1104.5 5.9%   
Avg Mkt Cap Rs m443,622489,231 90.7%   
No. of employees `000NANA-   
Total wages/salary Rs m18,80115,265 123.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m81,84085,080 96.2%  
Other income Rs m6,8911,966 350.6%   
Total revenues Rs m88,73187,046 101.9%   
Gross profit Rs m13,82719,466 71.0%  
Depreciation Rs m8,1426,622 123.0%   
Interest Rs m6762,551 26.5%   
Profit before tax Rs m11,90012,259 97.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1154,487 47.1%   
Profit after tax Rs m9,7857,772 125.9%  
Gross profit margin %16.922.9 73.8%  
Effective tax rate %17.836.6 48.6%   
Net profit margin %12.09.1 130.9%  
BALANCE SHEET DATA
Current assets Rs m83,82352,947 158.3%   
Current liabilities Rs m38,28044,151 86.7%   
Net working cap to sales %55.610.3 538.3%  
Current ratio x2.21.2 182.6%  
Inventory Days Days10119 529.5%  
Debtors Days Days927 1,310.7%  
Net fixed assets Rs m117,18473,115 160.3%   
Share capital Rs m6,003846 709.4%   
"Free" reserves Rs m76,28158,683 130.0%   
Net worth Rs m82,28459,530 138.2%   
Long term debt Rs m39,98521,232 188.3%   
Total assets Rs m201,007126,062 159.5%  
Interest coverage x18.65.8 320.4%   
Debt to equity ratio x0.50.4 136.2%  
Sales to assets ratio x0.40.7 60.3%   
Return on assets %5.28.2 63.6%  
Return on equity %11.913.1 91.1%  
Return on capital %10.318.3 56.1%  
Exports to sales %00-   
Imports to sales %7.80-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m6,360NA-   
Fx inflow Rs m8,88518,419 48.2%   
Fx outflow Rs m6,3603,337 190.6%   
Net fx Rs m2,52515,082 16.7%   
CASH FLOW
From Operations Rs m11,76618,030 65.3%  
From Investments Rs m-16,991-1,966 864.1%  
From Financial Activity Rs m2,421-17,811 -13.6%  
Net Cashflow Rs m-2,433-1,742 139.7%  

Share Holding

Indian Promoters % 39.7 71.3 55.7%  
Foreign collaborators % 21.0 0.0 -  
Indian inst/Mut Fund % 23.6 20.9 112.8%  
FIIs % 15.8 11.4 138.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 28.8 136.9%  
Shareholders   369,816 67,866 544.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on Biocon vs Torrent Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs Torrent Pharma Share Price Performance

Period Biocon Torrent Pharma S&P BSE HEALTHCARE
1-Day -0.63% -1.36% -0.10%
1-Month 5.56% -4.27% -1.99%
1-Year -22.75% 8.97% -5.62%
3-Year CAGR -0.26% 19.67% 20.96%
5-Year CAGR -11.19% 20.09% 11.47%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the Torrent Pharma share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of Torrent Pharma the stake stands at 71.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Torrent Pharma.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.1%.

Torrent Pharma paid Rs 48.0, and its dividend payout ratio stood at 104.5%.

You may visit here to review the dividend history of Biocon, and the dividend history of Torrent Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.